Rates of overweight and obesity have more than doubled in the United States during the last three decades, according to a new analysis. By 2050, it’s anticipated that 213 million adults (age, > 25 ...
GLP-1 medications like Ozempic and Zepbound are transforming chronic disease and weight management, with perimenopausal women among the most common users. Despite their high use in this group, women ...
The proportion of patients taking a GLP-1 weight-loss drug following bariatric surgery increased substantially in recent years, although the timing of initiation after surgery varied widely, a large ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Women who used a GLP-1 before pregnancy were more likely ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Diabetes management-dose GLP-1 use reduces recurrent ...
Credit: Getty Images In light of Serena Williams’s endorsement of GLP-1 medications, we interviewed an obesity medicine specialist about the implications of these medications for professional athletes ...
A new report based on national prescription data shows weight-loss drug use is rising among kids and teens. GLP-1 medications, like Ozempic and Wegovy, are drugs originally developed to treat diabetes ...
About one in eight U.S. adults (12%) say they are currently taking a GLP-1 medication such as Ozempic or Wegovy for weight loss, diabetes, heart disease or another chronic condition, a new KFF Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results